An Open-Label, Randomized, Phase 3 Clinical Trial of REGN2810 Versus Investigator’s Choice of Chemotherapy in Recurrent or Metastatic Cervical Carcinoma.
Kolejna witryna oparta na WordPressie
PARTNERZY
PARTNERZY
An Open-Label, Randomized, Phase 3 Clinical Trial of REGN2810 Versus Investigator’s Choice of Chemotherapy in Recurrent or Metastatic Cervical Carcinoma.